TENOFOVIR ALAFENAMIDE , Sodium chloride solution 0.9%, ENTECAVIR , TENOFOVIR DISOPROXIL , JNJ-73763989
Phase 2 small_molecule active
Quick answer
TENOFOVIR ALAFENAMIDE , Sodium chloride solution 0.9%, ENTECAVIR , TENOFOVIR DISOPROXIL , JNJ-73763989 for Hepatitis B and Hepatitis D Viral Co-infection is a Phase 2 program (small_molecule) at Janssen-Cilag International N.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Janssen-Cilag International N.V.
- Indication
- Hepatitis B and Hepatitis D Viral Co-infection
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active